New Zealand
Greenfern Industries (NZX:GFI) is a pioneering company in the field of cannabis therapeutics, placing a strong emphasis on patient care, environmental sustainability, and hydropower. Established in 2018, the company is publicly listed on the NZX stock exchange under the ticker symbol GFI.
Greenfern's operations encompass licensed medicinal cannabis and biotechnology, as well as ventures into industrial hemp, hemp food, and body care products. The company's primary facilities, including a medicinal cannabis research facility and hemp processing hub, are located in Normanby, South Taranaki, leveraging renewable energy from its own hydroelectric power station on the Waingongoro River.
Emphasizing environmentally friendly production, Greenfern's research facility operates with optimal efficiency and sustainability, using renewable power and an aeroponic production system known for water and nutrient efficiency. Its hemp production follows the same ethos, with the seed and by-products utilized in various applications, including high-protein ingredients, plant-based meat substitutes, skincare products, and beverages.
Notably, Greenfern holds certifications as a B Corp Certified entity and as a Toitū net carbonzero certified organization, marking its commitment to environmental responsibility. The company secured a NZD4.00M Equity Crowdfunding investment on 02 September 2020, demonstrating investor confidence in its vision and operations.
Headquarter: New Zealand
